These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 191714)
1. The adnosine 3',5'-monophosphate and guanosine 3',5'-monophosphate phosphodiesterases from human lung tissue. Green D; Guy G; Moore JB Life Sci; 1977 Apr; 20(7):1157-62. PubMed ID: 191714 [No Abstract] [Full Text] [Related]
2. Effects of antiallergic agents, compound 48/80, and some reference inhibitors on the activity of partially purified human lung tissue adenosine cyclic 3',5'-monophosphate and guanosine cyclic 3',5'-monophosphate phosphodiesterases. Bergstrand H; Kristoffersson J; Lundquist B; Schurmann A Mol Pharmacol; 1977 Jan; 13(1):38-43. PubMed ID: 189182 [No Abstract] [Full Text] [Related]
3. Effect of SCH 15280, a new bronchodilator, on cyclic 3',5'-nucleotide phosphodiesterase activity and cyclic 3',5'-adenosine monophosphate levels in guinea pig lung. Kreutner W; Sherwood JE Biochem Pharmacol; 1977 May; 26(10):951-4. PubMed ID: 193512 [No Abstract] [Full Text] [Related]
4. Inhibitory and activators of cyclic nucleotide phosphodiesterase. Chasin M; Harris DN Adv Cyclic Nucleotide Res; 1976; 7():225-64. PubMed ID: 188316 [No Abstract] [Full Text] [Related]
5. Comparison of in vivo and in vitro properties of cyclic adenosine 3':5'-monophosphate phosphodiesterase of amphibian oocytes. Allende CC; Bravo R; Allende JE J Biol Chem; 1977 Jul; 252(13):4662-6. PubMed ID: 194890 [No Abstract] [Full Text] [Related]
6. Properties and drug responsiveness of cyclic nucleotide phosphodiesterases of rat lung. Fertel R; Weiss B Mol Pharmacol; 1976 Jul; 12(4):678-87. PubMed ID: 183099 [No Abstract] [Full Text] [Related]
7. Cyclic nucleotide phosphodiesterases of human and rat gastric mucosa. Klotz U; Antonin KH; Bieck P Naunyn Schmiedebergs Arch Pharmacol; 1977 Jan; 296(2):187-90. PubMed ID: 189231 [No Abstract] [Full Text] [Related]
8. Ontogenetic changes in levels of phosphodiesterase for adenosine 3':5'-monophosphate and glucosine 3':5'-monophosphate in the lung, brain and heart from guinea pigs. Davis CW; Kuo JF Biochim Biophys Acta; 1976 Sep; 444(2):554-62. PubMed ID: 183829 [TBL] [Abstract][Full Text] [Related]
9. Cyclic nucleotide hydrolysis in the thyroid gland. General properties and key role in the interrelations between concentrations of adenosine 3':5'-monophosphate and guanosine 3':5'-monophosphate. Erneux C; Van Sande J; Dumont JE; Boeynaems JM Eur J Biochem; 1977 Jan; 72(1):137-47. PubMed ID: 12974 [TBL] [Abstract][Full Text] [Related]
10. Role of phosphodiesterases III and IV in the modulation of vascular cyclic AMP content by the NO/cyclic GMP pathway. Eckly AE; Lugnier C Br J Pharmacol; 1994 Oct; 113(2):445-50. PubMed ID: 7834194 [TBL] [Abstract][Full Text] [Related]
11. Cyclic AMP phosphodiesterase activity in fetal and adult muscle of the rhesus monkey. Bocek RM; Beatty CH Dev Biol; 1976 Feb; 48(2):382-91. PubMed ID: 176071 [No Abstract] [Full Text] [Related]
12. Calcium-dependent cyclic nucleotide phosphodiesterase from brain: comparison of adenosine 3',5'-monophosphate and guanosine 3',5'-monophosphate as substrates. Brostrom CO; Wolff DJ Arch Biochem Biophys; 1976 Jan; 172(1):301-11. PubMed ID: 175742 [No Abstract] [Full Text] [Related]
13. Comparison of cyclic adenosine 3':5'-monophosphate and cyclic guanosine 3':5'-monophosphate levels, cyclases, and phosphodiesterases in Morris hepatomas and liver. Hickie RA; Thompson WJ; Strada SJ; Couture-Murillo B; Morris HP; Robison GA Cancer Res; 1977 Oct; 37(10):3599-606. PubMed ID: 20224 [No Abstract] [Full Text] [Related]
14. Cyclic nucleotide phosphodiesterases in dystrophic rat retinas: guanosine 3',5' cyclic monophosphate anomalies during photoreceptor cell degeneration. Lolley RN; Farber DB Exp Eye Res; 1975 Jun; 20(6):585-97. PubMed ID: 168094 [No Abstract] [Full Text] [Related]
15. Activity of imidazole on the hydrolysis of cyclic AMP and cyclic GMP by bovine heart and rat liver cyclic nucleotide phosphodiesterases. Donnelly TE Arch Biochem Biophys; 1976 Mar; 173(1):375-85. PubMed ID: 4034 [No Abstract] [Full Text] [Related]
16. Cyclic 3',5'-nucleotide phosphodiesterase in rat skin. II. Biochemical characterization. King LE; Solomon SS; Hasimoto K J Invest Dermatol; 1975 Jun; 64(6):390-6. PubMed ID: 237964 [TBL] [Abstract][Full Text] [Related]
17. Inhibition of human lung cyclic GMP and cyclic AMP phosphodiesterases by certain nucleosides, nucleotides, and pharmacological phosphodiesterase inhibitors. Glass WF; Moore JB Biochem Pharmacol; 1979 Apr; 28(7):1107-12. PubMed ID: 87197 [No Abstract] [Full Text] [Related]
18. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung. Davis CW; Kuo JF Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285 [No Abstract] [Full Text] [Related]
19. Bovine luteal cyclic AMP and cyclic GMP phosphodiesterase activity; sensitivity to various drugs and hormones. Goff AK; Major PW FEBS Lett; 1976 Jan; 61(2):144-7. PubMed ID: 174943 [No Abstract] [Full Text] [Related]